Samuel F. Hunter, MD, PhD

All articles by Samuel F. Hunter, MD, PhD

Novel Class of Preventive Treatments for Migraine

June 17, 2020

Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.

Next post in Medicine

Samuel F. Hunter, MD, PhD

All articles by Samuel F. Hunter, MD, PhD

Novel Class of Preventive Treatments for Migraine

Worsened ADHD Behaviors Reported for Children During COVID-19